Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
S-1 and Gemcitabine in Metastatic Pancreatic Cancer
NCT00209677Phase 2Suspended
- Sponsor
- Hokkaido Gastrointestinal Cancer Study Group
- Start
- Dec 2004
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of tegafur, gemcitabine in pancreatic cancer (PC), sponsored by Hokkaido Gastrointestinal Cancer Study Group. Started Dec 2004; status: suspended.
02
Drugs
tegafurgemcitabine
03
Conditions
pancreatic cancer (PC)
Beyond the preview
Go deeper on NCT00209677.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00209677.